Bixia Lin

ORCID: 0000-0001-8796-1645
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Advanced biosensing and bioanalysis techniques
  • Molecular Sensors and Ion Detection
  • Advanced Nanomaterials in Catalysis
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Ginger and Zingiberaceae research
  • Pharmacogenetics and Drug Metabolism
  • Alzheimer's disease research and treatments
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Drug-Induced Hepatotoxicity and Protection
  • Neurological Disease Mechanisms and Treatments
  • Luminescence and Fluorescent Materials

First Affiliated Hospital of Fujian Medical University
2021-2024

Fujian Medical University
2021-2024

Introduction. The advances in cerebral ischemia treatment have resulted a larger proportion of patients get the benefits rebuilding blood flow to brain. Then, ischemia-reperfusion injury has emerged as new essential problem. Dectin-1 plays an important role by regulating function immune cells. Methods. C57BL/6 was blindly divided into four groups including sham-operated group and three different kinds middle artery occlusion (MCAO) (after 6 hours, 12 24 hours after plug removal). protein...

10.1155/2021/6697271 article EN cc-by Emergency Medicine International 2021-05-21

Deferasirox (DEF) is essential for patients with thalassemia requiring long-term transfusion therapy. Tigecycline (TIGE) a first-line drug the clinical treatment of complex, severe bacterial infections. Easy and efficient techniques monitoring these two drugs in biological samples are few. Metal–organic framework (Zn-MOF) prepared from zinc nitrate hexahydrate dithioglycolic acid has flower structure. Interestingly, Zn-MOF can cause DEF to aggregate on it induce luminescence. The principle...

10.2139/ssrn.4421967 preprint EN 2023-01-01
Coming Soon ...